JamesEdwardMoonMDFACP, FIDSA

Infectious Disease • Silver Spring, MD

Director, Special Projects, Chief, Safety Operations, and Chair, Scientific Review Committee (SRC), Walter Reed Army Institute of Research (WRAIR)

Join to view full profile

Dr. Moon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Moon's full profile

Already have an account?

Office
503 Robert Grant Avenue
Silver Spring, MD 20910

Summary

Dr. James Moon is an Infectious Disease specialist based in Silver Spring, MD, with a medical degree from Pennsylvania State University College of Medicine and a fellowship in Infectious Disease from the San Antonio Uniformed Services Health Education Consortium. He currently serves in multiple positions at the Walter Reed Army Institute of Research and is an Associate Professor of Medicine at the Uniformed Services University of the Health Sciences. Dr. Moon's expertise includes malaria, clinical research, and clinical trials. He has contributed to several notable publications, including research on malaria and Ebola vaccines, and has conducted multiple clinical trials related to malaria and dengue.

Education & Training

San Antonio Uniformed Services Health Education ConsortiumFellowship, Infectious Disease, 2003 - 2006
Tripler Army Medical CenterResidency, Internal Medicine, 2000 - 2003
Pennsylvania State University College of MedicineClass of 2000

Certifications & Licensure

HI State Medical License 2002 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Clinical Trials

Merozoite Surface Protein 1 Antibody Response in Asymptomatic Human Malaria Infection Start of enrollment: 2008 Sep 01
Completed
Not Applicable
Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performance Start of enrollment: 2012 Feb 01
Completed
Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines Start of enrollment: 2012 Jan 01
Completed
Phase 1
Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever Start of enrollment: 2014 Jul 09
Completed
Phase 2
Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of the Plasmodium Falciparum Vaccine Candidate FMP012 Administered Intramuscularly With AS01B Adjuvant System in Healthy Malaria-Naïve Adults Start of enrollment: 2014 Aug 01
Completed
Phase 1
A Clinical Trial of the PfSPZ Vaccine Administered by Direct Venous Inoculation in Healthy Malaria-Naïve Adults: Heterologous vs. Homologous Controlled Human Malaria Infection and Reduction in Number of Doses Start of enrollment: 2014 Jun 01
Completed
Phase 1
TDENV PIV and LAV Dengue Prime-boost Strategy Start of enrollment: 2014 Dec 01
Completed
Phase 1
Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001) Start of enrollment: 2014 Oct 13
Completed
Phase 1
Genetic Variability in CYP2D6 in U.S Active Duty Population Start of enrollment: 2016 Jan 08
Completed
Phase 1
Evaluate the Infectivity Equivalence of Current and New Lots of Plasmodium Falciparum Strain NF54 Start of enrollment: 2019 Mar 04
Completed
Phase 1
A Trial For The Study of Falciparum Malaria Protein 013 Administered Via Intramuscular Injection in Healthy Adults Start of enrollment: 2020 Mar 20
Recruiting
Phase 1
A Trial For The Study of Falciparum Malaria Protein 014 Administered Via Intramuscular Injection in Healthy Adults Start of enrollment: 2020 Mar 20
Recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

Phase 1 clinical trial of Hantaan and Puumala virus DNA vaccines delivered by needle-free injection.
Jay W Hooper, Steven A Kwilas, Matthew Josleyn, Sarah Norris, Jack N Hutter
NPJ Vaccines. 2024-11-17
14 citations
A candidate antibody drug for prevention of malaria.
Katherine L Williams, Steve Guerrero, Yevel Flores-Garcia, Dongkyoon Kim, Kevin S Williamson
Nature Medicine. 2024-01-01
2 citations
Cross-Cutting Lessons Learned During the COVID-19 Pandemic-the Walter Reed Army Institute of Research Experience.
Jeffrey M Osgood, Jeffrey W Froude, Sherri P Daye, Oscar A Cabrera, Matthew R Scherer
Military Medicine. 2023-01-04

Press Mentions

These Volunteers Want to Get Malaria. Why? A Better VaccineJune 18th, 2018

Professional Memberships

Infectious Disease Society of America - IDSA
Fellow
American College of Physicians - ACP
Fellow
American Society for Tropical Medicine and Hygiene
Member
Armed Forces Infectious Disease Society
Member